1. MARKETS
  2. SECTOR : HEALTHCARE
  3. INDUSTRY : HEALTHCARE FACILITIES
  4. GLOBAL HEALTH LTD.
Global Health Ltd.
NSE: MEDANTA | BSE: 543654

Global Health Live Share Price Today, Share Analysis and Chart

aboutGlobal Health Limited (Medanta) is a prominent private multi-specialty tertiary care provider in North and East India. Founded by cardiac surgeon Dr. Naresh Trehan, the company operates under the Medanta brand, delivering complex quaternary care ... Read More
Occupancy RateARPOB (Rev per Bed)
Ask AI about Global Health
1454.0014.30(0.99%)
135.3K
NSE+BSE Volume

NSE 13 Nov, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Global Health Stock Price Analysis

Day Price Range

1.0% 1 Day return
1454 (LTP)
1,4351,465
LowHigh

Week Price Range

4.0% 1 Week return
1454 (LTP)
1,390.81,465
LowHigh

Month Price Range

14.0% 1 Month return
1454 (LTP)
1,1651,465
LowHigh

52 Week Price Range

23.8% 1 Year return
1454 (LTP)
9561,544
LowHigh

Global Health Forecaster - Analyst Share Price Target and Estimates

Revenue forecast

EPS forecast

CURRENT EPS
20.7
AVG. ESTIMATE
28.5
LOW ESTIMATE
24.9
HIGH ESTIMATE
30.1
CURRENT EPS
AVG. ESTIMATE

Consensus Recommendation

19 ANALYST Recommendations
STRONG BUY
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get

Global Health Technical Analysis

Global Health EMA & SMA

Bullish+8
8 bullish, 0 bearish
Bullish8
Bearish0
5 Day1428.7
10 Day1396.3
12 Day1386.0
20 Day1362.6
26 Day1356.9
50 Day1357.0
100 Day1343.1
200 Day1303.0

Global Health Delivery And Volume

Daily Avg. Delivery Volume %
13 Nov, 202658.4%
Week58.8%
Month57.5%

Global Health Active Candlesticks

Short Line Uptrend Spinning Top Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Global Health Resistance and Support

1451.33
Pivot
First Resistance1467.7
Second Resistance1481.3
Third Resistance1497.7
First Support1437.7
Second Support1421.3
Third Support1407.7
Day RSI68
Day MACD29.1
Day MFI95.9
Day MACD Signal Line7.3

Global Health Beta

1 Month0.2
1 Year0.7
3 Month0.3
3 Year0.6

Global Health Price Change Analysis

↑14.0%
Over 1 Month
LowHigh
11651465
↑2.2%
Over 3 Months
LowHigh
11651544
↑17.0%
Over 6 Months
LowHigh
11531544
↑23.8%
Over 1 Year
LowHigh
9561544

Global Health Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Naresh Kumar TrehanPromoter88,725,45733 %
Government Pension Fund GlobalFii8,313,4783.1 %
Dunearn Investments (Mauritius) Pte LtdPublic39,900,99014.8 %
Invesco India Business Cycle FundDii13,895,9025.2 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Global Health Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SUNIL SACHDEVABlockSell25 Jun 202613001,000,000BSE
HDFC MUTUAL FUNDBlockPurchase25 Jun 202613001,000,000BSE
SUNIL SACHDEVABlockSell25 May 202612251,000,000NSE
HDFC MUTUAL FUNDBlockPurchase25 May 202612251,000,000NSE
JM FINANCIAL INSTITUTIONAL SECURITIES LIMITEDBulkPurchase14 Feb 20241315.223,000,000BSE
DUNEARN INVESTMENTS MAURITIUS PTE LIMITEDBulkSell14 Feb 20241315.203,000,000BSE
JM FINANCIAL INSTITUTIONAL SECURITIES LIMITEDBulkSell14 Feb 20241315.053,000,000BSE
RJ CORP LIMITEDBulkPurchase14 Feb 202413152,882,203BSE
JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITEDBlockSell18 Jan 20241030.05297,792BSE
THE JUPITER GLOBAL FUND-JUPITER INDIA SELECTBlockPurchase18 Jan 20241030.05297,792BSE

Global Health Corporate Actions

Global Health Dividend history and yield

Global Health dividend yields, including actual and adjusted, and dividend history, including announcement, record, and ex-dividend dates. Track Global Health dividend yield over time.

#Ex-Date
Dividend AmountDividend TypeRecord DateInstrument Type
114 Aug 2026
0.5FINAL14 Aug 2026Equity Share
222 Aug 2025
0.5FINAL22 Aug 2025Equity Share

Global Health Board Meetings

Global Health past and upcoming board meetings.

#Ex-Date
PurposeNotes
103 Nov 2026
Quarterly Results-
230 Jul 2026
Quarterly Results-
314 May 2026
Audited Results & Final Dividend-
404 Feb 2026
Quarterly Results-
507 Nov 2025
Quarterly Results-

Global Health Research Reports

Global Health research reports with share price targets, and buy/hold/sell recommendations from top brokers.

#
Date
Broker NameTargetPrice When RecommendedTypeUpsideChange Since RecommendationLinks
110 Nov 2026Anand Rathi
Target
17101429Buy19.66%1.75%pdf
204 Nov 2026Axis Direct
Target
16151389.7Buy16.21%4.63%pdf
324 Aug 2026Prabhudas Lilladhar
Target
17501404.4Buy24.61%3.53%pdf
431 Jul 2026Motilal Oswal
Target
16701405.6Buy18.81%3.44%pdf
518 May 2026Anand Rathi14001240.4Buy12.87%17.22%pdf

Global Health Corporate Filings

Global Health BSE corporate filings and AGM, press releases, insider trading & SAST, results and corporate actions.

DateAnnouncement TitleDetailsLinks
14 Nov 2026
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation for the Analyst/Investors Meet .
PDF
10 Nov 2026
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
PDF
10 Nov 2026
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
PDF
10 Nov 2026
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
PDF
10 Nov 2026
Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Announcement under SEBI Listing Regulations, 2015 regarding schedule of Institutional investor meet.
PDF

Global Health Documents

Global Health Earnings Call

Global Health earnings calls, including management commentary and AI-generated summaries.

DateTitleLinks
10 Nov 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
04 Nov 2026Global Health Results Earnings Call for Q2FY27
05 Aug 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
31 Jul 2026Global Health Results Earnings Call for Q1FY27
20 May 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Global Health Annual Reports

Global Health financials, including annual results, balance sheets, and cash flow statements.

DateReport TitleLinks
2026Annual Report Mar-2026
2025Annual Report Mar-2025
2024Annual Report Mar-2024
2023Annual Report Mar-2023

Global Health Credit Ratings

Global Health credit ratings from CRISIL and leading rating agencies, assessing financial stability, investment grade, and related PDF documentation.

DateRating AgencyCompany NameDescriptionLinks
15 Dec 2025crisil ratingsGlobal Health LimitedGlobal Health Limited:Long-term rating upgraded to 'Crisil AA/Stable'; Short-term rating reaffirmed
09 Dec 2025crisil ratingsGlobal Health Research and Management InstituteGlobal Health Research and Management Institute:Issuer not cooperating, based on best-available information; Rating continues to be \u2018Crisil D Issuer not cooperating\u2019
15 Oct 2025crisil ratingsGlobal Health LimitedGlobal Health Limited:Update on Global Health Limited
14 Jul 2025brickwork ratingsGlobal Health Research and Management InstituteIssuer did not cooperate; Based on best available information; Continues to be in ISSUER NOT COOPERATING* category/Reaffirmed;
16 Mar 2025crisil ratingsGlobal Health LimitedGlobal Health Limited:Rated amount enhanced for Bank Debt

Global Health Investor Presentations

Global Health investor presentations, including business updates, financial insights, and strategic initiatives.

DateReport TitleLinks
14 Nov 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
03 Nov 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
30 Jul 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
14 May 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation
04 Feb 2026Global Health Ltd - 543654 - Announcement under Regulation 30 (LODR)-Investor Presentation

Global Health - Company Profile

Global Health Management Structure

Global Health management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Mr. Vishvajeet KumarHospital Director-Mar 26
Mr. Jagdeep SinghGeneral Manager-Mar 26
Mr. Pradeep Kumar SinghChief Digital Officer-Mar 26
Mr. Kedar ApteChief Marketing Officer-Mar 26
Mr. Malik Mohd. AshhabHead(Diagnostics,Services)-Mar 26
Dr. Pankaj DhamijaHospital Director-Mar 26
Mr. Mahi TandonHospital Director-Mar 26
Dr. Vishal SehgalHead(Outreach Business)-Mar 26
Dr. Sanjay GeedMedical Director-Mar 26
Mr. Brajesh Kumar SinghDirector(Projects)-Mar 26
RAHUL RANJANCompany Secretary,Compliance Officer-Mar 26
Dr. Ravi Shankar SinghMedical Director-Mar 26
Dr. Rakesh KapoorMedical Director-Mar 26
Ms. Richa SinghGeneral Manager-Mar 26
Mr. Saurabh UpadhyaySenior Vice President,Head(Human Resources)-Mar 26
Mr. Rajiv SikkaChief Information Officer-Mar 26
Mr. Bhuvander KaulChief Procurement Officer-Mar 26
Dr. Sandeep SawhneySenior Vice President(Strategic Planning)-Mar 26
Mr. Yogesh Kumar GuptaChief Financial Officer-Mar 26
Pankaj Prakash SahniExecutive Director,Chief Executive Officer-Mar 26

Global Health Board of Directors

Global Health Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Naresh Kumar TrehanChairman / Executive Director / Managing Director718.51Mar 26
Pankaj Prakash SahniDirector & Group CEO565.57Mar 26
Vikram Singh MehtaIndependent Non Exe. Director43Mar 26
Praveen MahajanIndependent Non Exe. Director42Mar 26
RAVI GUPTAIndependent Non Exe. Director41Mar 26
Rajan Bharti MittalIndependent Non Exe. Director35Mar 26
Hari S BhartiaIndependent Non Exe. Director27Mar 26
Shonan Purie TrehanNon-Exec & Non-Independent Dir-Mar 26
RAHUL RANJANCompany Sec. & Compli. Officer-Mar 26
RAVI KANT JAIPURIANon Executive Director / Nominee-Mar 26
Sunil SachdevaNon-Exec & Non-Independent Dir-Mar 26

About the company - Business Profile

Global Health Limited (Medanta) is a prominent private multi-specialty tertiary care provider in North and East India. Founded by cardiac surgeon Dr. Naresh Trehan, the company operates under the Medanta brand, delivering complex quaternary care across a network of super-specialty hospitals. It maintains a leadership position in several high-demand specialties including cardiac sciences, neurosciences, oncology, and liver transplants.

Key Points

  • Key Facts:
    • Founded: 2004 (Flagship hospital opened in 2009).
    • Headquarters: New Delhi, India.
    • Stock Listing: Listed on BSE and NSE on November 16, 2022.
    • Core Offerings: Multi-specialty healthcare services across 30+ medical specialties.
  • Operations and Resources:
    • Network: Operates 6 hospitals in Gurugram, Indore, Ranchi, Lucknow, Patna, and a newly operational unit in Noida (commenced 2025).
    • Capacity: As of December 31, 2025, the company had 3,550+ installed beds.
    • Flagship Asset: Medanta - The Medicity (Gurugram) is the largest single-location private hospital in the National Capital Region (NCR), with 1,440 installed beds and 40 operation theatres.
    • Expansion: Developing new facilities in Pitampura (750 beds), South Delhi (400 beds), and Guwahati (400 beds).
  • Market Significance and Business Model:
    • Business Model: Medanta follows a doctor-led model focusing on high-end tertiary and quaternary care (complex medical procedures).
    • Patient Reach: Serves a population base of over 400 million people across North and East India and treats international patients from 130+ countries.
  • Financial Performance (FY 2024-25):
    • Total Income: Rs. 37,714 million (reflecting a 26% CAGR from FY 2021).
    • EBITDA: Rs. 9,562 million with an EBITDA margin of 25.4%.
    • Profit After Tax (PAT): Rs. 4,813 million (102% CAGR since FY 2021).
    • ARPOB (Average Revenue Per Occupied Bed): Rs. 62,722 per day in FY 2025.
    • Revenue Breakdown: Primarily derived from hospital and medical care services (90%+ of turnover).
  • Technology and Innovation:
    • Medical Equipment: Utilization of Da Vinci Xi Single robotic system and Magnetom Vida MRI System.
    • Specialized Units: Recently launched a dedicated floor for mother and child at the Gurugram facility with 49 beds.
  • Human Resources:
    • Workforce: Engages over 1,800+ doctors and a total staff of approximately 10,500+ employees (including 6,250+ nurses and paramedics).
    • Incentives: Implemented the Global Health Limited Employees Long-Term Share-Based Incentive Plan-2024.
  • Current Strategic Initiatives:
    • Bed Capacity Growth: Targeted to reach a total capacity of over 5,000 beds through ongoing expansions in Noida, Delhi, and Guwahati.
    • Integration: Focused on digital health initiatives and expanding Medanta Labs (10 labs and 120 collection centers) and pharmacies.

References

  1. Annual Report May 2025
  2. Investor Presentation Feb 2026
  3. Investor Presentation Nov 2025
  4. Annual Report May 2024
  5. Quarterly Results Nov 2025

Global Health FAQ

Global Health today is trading in the green, up by 0.99% at ₹1,454.
Global Health is currently trading up 0.99% on an intraday basis. In the past week the stock rose 4.04%. Stock has been up 2.21% in the past quarter and rose 23.76% in the past year. You can view this in the share price history/seasonality section.
Global Health is listed on NSE with the ticker MEDANTA and on BSE as 543654. It's currently trading on NSE at a share price of ₹1,454 and on BSE with a share price of ₹1,450.5.
The market cap of Global Health is ₹39,094.79 Cr. as of Nov 13, 2026.
Global Health announced a FINAL dividend of 25% which equals ₹0.5 in Aug 14, 2026.The last ex-date for Global Health was Aug 22, 2025. To view the full dividend history of Global Health click here.
Global Health has never issued stock splits or bonus shares since the time of its listing on the BSE/NSE exchanges.
Global Health reported ₹1,492.66 Cr. in revenue, ₹220.67 Cr. in net profit, and ₹393.71 Cr. in EBITD as of Nov 03, 2026 for Q2 FY26-27.
According to the predictions of 19 analysts, the share price prediction for Global Health is ₹1,667.74 with an upside of 15%.
The PE ratio of Global Health is 63.22 as of Nov 13, 2026.
The PB ratio of Global Health is 9.49 as of Nov 13, 2026.
You can view the latest analyst reports on the Global Health reports dashboard. Either click on the Reports tab on this page's sub-header or click here to be directed to the dashboard.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.